Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

This study is collecting information about quality of life and patient-reported symptoms in people — both children and adults — diagnosed with a rare type of lymphoma called nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Researchers want to better understand how this disease and its treatment affect patients' day-to-day lives. **You may be eligible if...** - You are 8 years of age or older - You or your adult caregiver can read and speak English - You have been confirmed by pathology to have nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), including if the lymphoma has transformed to a more aggressive type - You or your guardian are able to complete electronic quality-of-life surveys **You may NOT be eligible if...** - You are 7 years old or younger - You or your adult representative cannot communicate in English - You have a composite lymphoma diagnosis (NLPHL combined with another type of lymphoma at the same time as initial diagnosis) - You or your guardian are unable or unwilling to provide consent Talk to your doctor to see if this trial is right for you.